Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
Expanding insights into cancer with real-world data on solid tumors Cancer comes in many forms, including hematologic malignancies that originate...
Sustainability spotlight: How COTA is approaching corporate ecological responsibility Since the turn of the century, there’s been a growing recognition...
Using AI to transform life sciences data analysis: An early look at CAILIN’s performance COTA has launched the COTA...
Discover the power of real-world cancer data for your life science organization.
